Digital asset finance company Propanc Biopharma secures up to $100 million strategic financing agreement

ChainCatcher news, digital asset finance company Propanc Biopharma announced a strategic financing agreement with family office Hexstone Capital for up to $100 million.

This financing will accelerate the development of the biopharmaceutical company's clinical pipeline and aims to increase the value of its digital asset portfolio to $100 million or more within the next 12 months. Hexstone Capital has previously invested in several companies with digital asset portfolios, involving various digital assets such as BTC, ETH, SOL, and DOGE.